DHRS12 inhibits the proliferation and metastasis of osteosarcoma via Wnt3a/β-catenin pathway

Future Oncol. 2020 Apr;16(11):665-674. doi: 10.2217/fon-2019-0432. Epub 2020 Apr 6.

Abstract

Aim: This experimental design was based on DHRS12 to explore its biological effects on osteosarcoma (OS). Materials & methods: The expression level of endogenous DHRS12 was analyzed by immunohistochemical analysis. DHRS12 was overexpressed in MG-63 and HOS cells by plasmid transfection. Cell proliferation, invasion, migration, apoptosis and western blot were used in the experiment. Results: The expression of DHRS12 was significantly reduced in OS. Overexpression of DHRS12 inhibited the proliferation, migration and invasion of MG-63 and HOS cells and induced apoptosis of OS cells. Overexpression of DHRS12 upregulated Bax, Caspase 9 and Caspase 3. Overexpression of DHRS12 resulted in inactivation of the Wnt3a/β-catenin signaling pathway. Conclusion: Overexpression of DHRS12 inhibited the progression of OS via the Wnt3a/β-catenin pathway.

Keywords: DHRS12; Wnt3a/β-catenin; invasion; osteosarcoma; proliferation.

MeSH terms

  • Animals
  • Apoptosis
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Down-Regulation
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mice
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplasm Transplantation
  • Osteosarcoma / genetics
  • Osteosarcoma / metabolism
  • Osteosarcoma / mortality
  • Osteosarcoma / pathology*
  • Short Chain Dehydrogenase-Reductases / genetics
  • Short Chain Dehydrogenase-Reductases / metabolism*
  • Survival Rate
  • Wnt Signaling Pathway*
  • Wnt3A Protein / metabolism
  • beta Catenin / metabolism

Substances

  • CTNNB1 protein, human
  • WNT3A protein, human
  • Wnt3A Protein
  • beta Catenin
  • DHRS12 protein, human
  • Short Chain Dehydrogenase-Reductases